Livemint

US-India interim trade deal extends tariff shield for Indian pharma, but with riders

The India-US joint statement highlights the provisional exclusion of Indian pharmaceutical exports comprising generic drugs including antibiotics, vaccines, bulk drugs and intermediates, from reciprocal tariffs but it is subject to the successful conclusion of the interim agreement